Skip to main content

De Burlo Group Inc

SEC CIK
0001134288
Latest filing
Aug 13, 2026

ABT holding history

Abbott Laboratories in every 13F filed by De Burlo Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of ABT by De Burlo Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−2,733−100.0%Sold outHolders
Q1 20262,733$280.6K0.1%−5,800−68.0%ReducedHolders
Q4 20258,533$1.07M0.1%−50−0.6%ReducedHolders
Q3 20258,583$1.15M0.1%+100+1.2%AddedHolders
Q2 20258,483$1.15M0.2%−150−1.7%ReducedHolders
Q1 20258,633$1.15M0.2%−100−1.1%ReducedHolders
Q4 20248,733$987.8K0.1%−1,100−11.2%ReducedHolders
Q3 20249,833$1.12M0.1%−3,200−24.6%ReducedHolders
Q2 202413,033$1.35M0.2%−1,350−9.4%ReducedHolders
Q1 202414,383$1.63M0.2%−1,000−6.5%ReducedHolders
Q4 202315,383$1.49M0.3%00.0%UnchangedHolders
Q3 202315,383$1.49M0.3%−650−4.1%ReducedHolders
Q2 202316,033$1.75M0.3%−200−1.2%ReducedHolders
Q1 202316,233$1.64M0.3%00.0%UnchangedHolders
Q4 202216,233$1.78M0.4%−200−1.2%ReducedHolders
Q3 202216,433$1.59M0.4%+9,620+141.2%AddedHolders
Q2 20226,813$740.0K0.2%−9,770−58.9%ReducedHolders
Q1 202216,583$1.96M0.4%−95,000−85.1%ReducedHolders
Q4 2021111,583$15.7M2.3%+9,300+9.1%AddedHolders
Q3 2021102,283$12.1M2.0%+85,400+505.8%AddedHolders
Q2 202116,883$1.96M0.3%−121,100−87.8%ReducedHolders
Q1 2021137,983$16.5M3.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.